Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Treatment of Community-Acquired Bacterial Pneumonia
.
Show all posts
Showing posts with label
Treatment of Community-Acquired Bacterial Pneumonia
.
Show all posts
Monday, January 16, 2017
Cempra Completes NDA Submissions for Solithromycin in the Treatment of Community-Acquired Bacterial Pneumonia
›
Cempra, Inc. , a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment ...
›
Home
View web version
